Does VALPROATE Cause Interstitial lung disease? 22 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Interstitial lung disease have been filed in association with VALPROATE (Valproate Sodium). This represents 0.1% of all adverse event reports for VALPROATE.
22
Reports of Interstitial lung disease with VALPROATE
0.1%
of all VALPROATE reports
8
Deaths
9
Hospitalizations
How Dangerous Is Interstitial lung disease From VALPROATE?
Of the 22 reports, 8 (36.4%) resulted in death, 9 (40.9%) required hospitalization, and 8 (36.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALPROATE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does VALPROATE Cause?
Foetal exposure during pregnancy (1,982)
Drug ineffective (1,268)
Seizure (1,083)
Epilepsy (878)
Somnolence (843)
Off label use (744)
Drug abuse (705)
Sopor (577)
Dysmorphism (552)
Drug interaction (513)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VALPROATE Alternatives Have Lower Interstitial lung disease Risk?
VALPROATE vs VALPROIC ACID
VALPROATE vs VALPROMIDE
VALPROATE vs VALSARTAN
VALPROATE vs VALTREX
VALPROATE vs VAMOROLONE